Clinical Trials Directory

Trials / Completed

CompletedNCT04754360

Cut-off Values of 6-min Walk Test and Sit-to-stand Test for Determining Symptom Burden and Functional Impairment in Atrial Fibrillation

Status
Completed
Phase
Study type
Observational
Enrollment
125 (actual)
Sponsor
Izmir Bakircay University · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Cut-off values indicating higher symptom burden and impairment in health status in 6-min walk test and 30-second sit-to-stand test in patients with atrial fibrillation will be determined in the study.

Detailed description

The 6-min walk test (6MWT) is the most used field test for measuring functional impairment in cardiopulmonary patients. However, to be able to objectively interpret 6MWT of a patient with specific chronic condition, the distance walked in 6MWT should be compared to either a healthy control group or a cut-off value that was specifically determined for that population. Such cut-off values are present for 6MWT in several cardiopulmonary diseases including COPD (350 m), heart failure (200 m) and pulmonary hypertension (400 m) for identifying patients with high mortality, poor prognosis and/or poor health status, but there is no cut-off value determined for atrial fibrillation (AF). The European Heart Rhythm Association (EHRA) score is a practical measure for assessing symptom burden and functional impairment caused by AF-related symptoms. While EHRA class 1 indicates asymptomatic patients, EHRA class 2, 3 and 4 indicates higher severities of symptom burden and functional impairment. Primary aim of this study is to determine a cut-off value in 6MWT for discriminating between the asymptomatic and symptomatic AF patients according to EHRA classification. In addition, a cut-off value for 30-second sit-to-stand test will be determined in these patients as well, since sit-to-stand tests have gained a lot of interest in the recent literature for practically evaluating functional status in various cardiopulmonary conditions.

Conditions

Interventions

TypeNameDescription
OTHEREvaluation of functional impairmentSymptom burden and functional impairment will be evaluated with EHRA Score, 6-min walk test and 30-second sit-to-stand test
OTHEREvaluation of pulmonary functionPulmonary function will be evaluated using basic spirometry and respiratory pressure meter.
OTHEREvaluation of quality of lifeQuality of life will be evaluated using Short Form-36 Questionnaire.
OTHEREvaluation of physical activity levelPhysical activity level will be evaluated using International Physical Activity Questionnaire Short Form

Timeline

Start date
2021-02-15
Primary completion
2021-05-10
Completion
2021-05-10
First posted
2021-02-15
Last updated
2021-10-19

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04754360. Inclusion in this directory is not an endorsement.